Beaufort Securities reiterated Venture Life Group Plc (LON:VLG) to Speculative Buy in a report released today.
- Updated: September 21, 2016
Yesterday Venture Life Group Plc (LON:VLG) traded -0.95% lower at 54.50GBX. The company’s 50-day moving average is 51.65GBX and its 200-day moving average is 56.47GBX. The last closing price is down -7.91% from the 200-day moving average, compared to the S&P 500 which has decreased -0.01% over the same time. 1,800 shares of the stock were exchanged, down from an average trading volume of 2,808
Beaufort Securities has reiterated Venture Life Group Plc (LON:VLG) to Speculative Buy in a report released on 09/22/2016.
Previously on 9/21/2016, Panmure Gordon reported on Venture Life Group Plc (LON:VLG) held steady the target price at 128.00GBX. At the time, this indicated a possible upside of 1.35%.
See Chart Below
Venture Life Group Plc has a 52 week low of 43.00GBX and a 52 week high of 81.92GBX The company’s market cap is currently 0 GBX.
In addition to Beaufort Securities reporting its target price, a total of 1 broker has issued a report on the stock. The consensus target price is 128.00GBX with 0 brokers rating the stock a strong buy, 1 broker rating the stock a buy, 0 brokers rating the stock a hold, 0 brokers rating the stock a underperform, and finally 0 brokers rating the stock a sell.
General Information About Venture Life Group Plc (LON:VLG)
Venture Life Group plc is an international consumer self-care company. The Company focuses on developing, manufacturing and commercializing products for the ageing population. Its segments include Brands, which includes sales of branded healthcare and cosmetics products direct to retailers and under distribution agreements, and Manufacturing, which includes sales of products and services under contract development and manufacturing agreements. Its product range includes the UltraDEX oral care range, which is primarily sold in the United Kingdom through the pharmacy and grocery retailers. Its product range also includes food supplements for lowering cholesterol and maintaining brain function, dermo-cosmetics for addressing the signs of ageing and medical devices for conditions, such as hemorrhoids, minor aches and pains, and women's intimate health issues. It also provides development and manufacturing services to other companies in the healthcare and skincare sectors.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.